Dexcom (DXCM) Net Income Growth (1y) (2011 - 2026)
Powered by 
Analysis
Dexcom (DXCM) Net Income Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.14 Bn | 177.54 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 125.03 Bn | 119.81 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 105.45 Bn | 101.97 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 66.16 Bn | 65.62 Bn | 3.85 Bn | 13.84% |
| 6 | Edwards Lifesciences | 49.54 Bn | 45.29 Bn | 1.35 Bn | -27.18% |
| 7 | Alcon | 33.69 Bn | 32.23 Bn | 1.68 Bn | -141.44% |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 21.01 Bn | 20.53 Bn | 684.20 Mn | 12.92% |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 30.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.54% |
| Mar 31, 2026 | 89.28% |
| Dec 31, 2025 | 76.20% |
| Sep 30, 2025 | 110.85% |
| Jun 30, 2025 | 25.30% |
| Mar 31, 2025 | -28.01% |
| Dec 31, 2024 | -40.81% |
| Sep 30, 2024 | 11.52% |
| Jun 30, 2024 | 23.81% |
| Mar 31, 2024 | 201.23% |
| Dec 31, 2023 | 179.19% |
| Sep 30, 2023 | 19.27% |
| Jun 30, 2023 | 127.70% |
| Mar 31, 2023 | -50.05% |
| Dec 31, 2022 | 1,832.08% |
| Sep 30, 2022 | 15.92% |
| Jun 30, 2022 | -35.08% |
| Mar 31, 2022 | 72.21% |
| Dec 31, 2021 | -101.29% |
| Sep 30, 2021 | 20.91% |